One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
Ramzi G. Salloum, PhD; Ka Loong Kelvin Au, MD; Michael S. Okun, MD
doi : 10.1001/jamaneurol.2022.2649
December 2022, Vol 79, No. 12, Pages 1217-1320
Racial and Ethnic Equity in Neuromuscular Care—Time for Our Action to Live Up to Potential
Neil C. Porter, MD; Lewis B. Morgenstern, MD
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy
Claude Steriade, MD; Jacqueline French, MD
Oscillating Between Guilt and Gratitude—Reflections of a Mother and Intensivist
Sarah Wahlster, MD
Genetic Testing in Patients With Epilepsy May Impact Treatments and Improve Outcomes
Joseph E. Sullivan, MD
Monogenic Stroke—Can We Overcome Nature With Nurture?
Ruchira M. Jha, MD, MSc
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson DiseaseA Randomized Clinical Trial
Kara N. Stevens, PhD; Siobhan Creanor, BSc; Alison Jeffery, PhD; et al.
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the USThe 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project
Jennifer J. Manly, PhD; Richard N. Jones, ScD; Kenneth M. Langa, MD, PhD; et al.
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer DiseaseA Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
Michael J. Pontecorvo, PhD; Ming Lu, MD, MS, MPH; Samantha C. Burnham, PhD; et al.
Association Between Alberta Stroke Program Early Computed Tomography Score and Efficacy and Safety Outcomes With Endovascular Therapy in Patients With Stroke From Large-Vessel OcclusionA Secondary Analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism—Japan Large Ischemic Core Trial (RESCUE-Japan LIMIT)
Kazutaka Uchida, MD, PhD; Seigo Shindo, MD, PhD; Shinichi Yoshimura, MD, PhD; et al.
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice
Dianalee McKnight, PhD; Ana Morales, MS; Kathryn E. Hatchell, PhD; et al.
Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment
Shahram Oveisgharan, MD; Robert J. Dawe, PhD; Lei Yu, PhD; et al.
Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Cerebral PalsyA Systematic Review and Meta-analysis
Siddharth Srivastava, MD; Sara A. Lewis, PhD; Julie S. Cohen, ScM, CGC; et al.
Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension
Corinna Doege, MD; Mark Luedde, MD; Karel Kostev, DMSc, PhD, MA
Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke
Bernard P. H. Cho, MSc; Eric L. Harshfield, PhD; Maha Al-Thani, MSc; et al.
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid BiomarkersA Review
Jeremy M. Shefner, MD, PhD; Richard Bedlack, MD, PhD; Jinsy A. Andrews, MD; et al.
Anti-LGI1–Associated Myopathy in the Setting of Neuromuscular Hyperexcitability Syndrome
Peter Anderyas, MBBS; Amy Halliday, BSc(Hons), MBBS; Katrina Reardon, MBBS, PhD
